Teva Reports Fourth Quarter and Full Year 2021 Financial Results | Business Wire
Teva Pharmaceutical Industries (NYSE:TEVA) earnings and shareholder returns have been trending downwards for the last five years, but the stock lifts 3.6% this past week
Teva: This One Is Difficult (NYSE:TEVA) | Seeking Alpha